Payment information/options
The way that payment works is that you will be invoiced half the cost when we start the gene syntheses for the immunogen. By default, antibody success is dependent on the reaction of the antigen that the user provides on the direct ELISA assay. The other half will be invoiced upon success. If for any reason you do not think the antibody generated successfully fulfills the success criteria, then please let us know. If we agree that this project is unsuccessful, then other half will not be invoiced.
If the project is not successful, if you wish, then we are able to make a second attempt for half of the cost of the project.
Downstream Application Insurance
As an additional risk mitigation option, users can specify a few downstream applications as the success criteria. Any additional criteria needs to be mentioned in the beginning of the project. Please note that this option would cost extra based on the downstream applications chosen.
If the antibody does not work for the requested downstream appliaction, then the customer will pay a reduce priced for the project.
We respect our customer's confidential information and guarantee that all intellectual property remains with the customer.
